Catheter Ablation of Cardiac Arrhythmias

33 Catheter Ablation of Cardiac Arrhythmias



One of the most important advances in cardiac electrophysiology over the last 30 years has been the introduction of fluoroscopically guided, catheter-based methods to cure or palliate arrhythmias. Symptomatic rhythm disturbances were formerly treated with potentially toxic drugs, open heart surgery, or a combination of the two. Catheter ablation has allowed the targeting and selective destruction of areas of the heart strategically important for the genesis or propagation of arrhythmias, using what is essentially a thin, flexible catheter inserted percutaneously and positioned under fluoroscopic guidance and electrophysiologic (EP) mapping. Today, this therapeutic modality has replaced cardiac surgery as the treatment of choice for almost all ventricular and supraventricular tachycardias (SVTs), particularly if antiarrhythmic drugs have been ineffective.



Energy Sources for Catheter Ablation


Initially, direct current (DC) shocks were delivered through the ablating catheter to achieve destruction of endocardial tissue. However, the effects of DC shock were often traumatic, unpredictable, and patchy. Blood surrounding the catheter tip could vaporize during the procedure and cause marked local injury to the myocardium. Not infrequently, the catheter tip also disintegrated. It then became apparent that radiofrequency (RF) energy, a type of alternating current (AC) already in use for electrocautery, could be modulated and applied through the catheter to create discrete and well-defined lesions. Subsequent experience showed that as long as tissue temperatures did not exceed 100°C, RF energy would not cause barotrauma. Furthermore, RF delivery is relatively painless and can be titrated to achieve the desired degree of tissue damage. Minimal muscle or nerve stimulation also meant that ablations could be performed without general anesthesia. Because of its safety and efficacy (Table 33-1), RF energy has become the preferred and most widely delivered form of energy for arrhythmia ablation.


Table 33-1 Outcomes of Catheter-Delivered Radiofrequency Ablation







































Type of Arrhythmia Success Rate (%) Complications (Rate)
AVNRT >95 AV block (1%), pericarditis or cardiac tamponade (0.3%)
AVRT



AV block (<1%), cardiac tamponade (0.1% to 1.1%), pericarditis (0.2%), stroke (0.15%), coronary artery dissection (rare)
AV node ablation 98–100 Sudden death (rare)
Atrial flutter

AV block (rare), stroke (rare)
Focal atrial tachycardia 86 AV block, cardiac tamponade, stroke, phrenic nerve damage (collectively 1%–2%)
Atrial fibrillation

Stroke (0.1% to 5%), cardiac tamponade (1%), LA flutter (up to 30%), phrenic nerve damage (<0.5%), PV stenosis (uncommon), atrioesophageal fistula (rare)
Idiopathic VT 85–100 Cardiac tamponade (Rare)
Ischemic VT 54–81 MI, stroke, arterial complications, death (1%–2%)

AF, atrial fibrillation; AP, accessory pathway; AV, atrioventricular; AVRT, atrioventricular reentrant tachycardia; AVNRT, atrioventricular nodal reentrant tachycardia; LA, left atrial; MI, myocardial infarction; PV, pulmonary vein; VT, ventricular tachycardia.


* Reported success rates vary widely, depending on definition of “success,” number of repeat ablations, quality of postoperative surveillance, and so forth.


In contrast to the household AC mains of 50 or 60 Hz, the RF current used for arrhythmia ablation alternates its polarity at between 300 and 1000 kHz, a frequency band high enough to prevent the induction of ventricular fibrillation when applied to the heart. Although RF energy works by thermal destruction of arrhythmogenic myocardium or abnormal conducting tissue, this heat does not arise from searing of the catheter tip. Rather, temperature builds up at the catheter tip–tissue interface, the point of highest resistance in the AC circuit. When resistive heating of cardiomyocytes in contact with the catheter tip exceeds 50°C for at least 10 seconds, coagulative necrosis occurs. Provided adequate tissue contact is maintained, the lesions created by RF energy are homogeneous and hemispheric in profile (roughly 3–5 mm in radius and 2–3 mm in depth). When cardiac tissue with intrinsic automaticity (e.g., a clump of cells driving an automatic tachycardia) is exposed to RF-induced heating, acceleration of the arrhythmia is seen. Conversely, RF treatment of a critical isthmus in a reentrant arrhythmia causes slowing or termination of the tachycardia.


Other types of transcatheter energy already in clinical use or currently under investigation include cryoablation (freezing), focused ultrasound, microwave, laser, and photocoagulation. RF ablation, rather than these less commonly used approaches, is the focus of this chapter.



Radiofrequency Catheter Ablation of Nodal Reentrant Tachycardias


Atrioventricular nodal reentrant tachycardia (AVNRT) is the most common type of paroxysmal SVT (Chapter 27). Although the exact nature of the tachycardia circuit remains uncertain, it is thought that the atrioventricular (AV) node and at least two discrete atrio-nodal tracts of different conduction velocities and refractoriness are involved in this arrhythmia. The most common type of AVNRT is referred to as slow-fast AVNRT. In individuals with slow-fast AVNRT, the “slow” atrio-nodal pathway, which is located in the inferior portion of the triangle of Koch (Fig. 33-1) between the coronary sinus (CS) ostium and tricuspid annulus, forms the antegrade limb of the tachycardia circuit, while the “fast” atrio-nodal pathway—located superior to and behind the tendon of Todaro, level with the apex of the triangle of Koch—conducts retrogradely to the atrium. Other forms of AVNRT have been described, such as fast-slow AVNRT, a type that propagates in a direction opposite to that just mentioned, and a third type that utilizes two slow pathways (slow-slow AVNRT).



The decision to use RF catheter ablation (RFCA) to treat AVNRT is a matter of clinical judgment and patient preference. If the tachycardia occurs frequently or is not well tolerated (either physically or psychologically), or if the patient is disinclined to try antiarrhythmic drugs, then RFCA may be recommended as first-line therapy, particularly given the improvements in RFCA in recent years. Enthusiasm for RFCA was initially limited, because early attempts to break the reentrant circuit by ablating the fast pathway—which lies in close proximity to the compact AV node and His bundle—were accompanied by an unacceptably high incidence of heart block (up to 20%). Following these early studies it was found that ablation or modification of the slow pathway (typically located further away from the AV node and His bundle) was equally effective and much safer. Mapping of the slow pathway is achieved by positioning the catheter within the inferior aspect of the triangle of Koch (see Fig. 33-1) and manipulating it until a delayed, multicomponent atrial potential (thought to represent slow-pathway depolarization) is recorded at the catheter tip. Alternatively, fluoroscopy and anatomic landmarks can be used to localize a specific site where the local ventricular deflection is much larger than the atrial signal. RF energy is then applied to this site. The goal of this overall strategy is to initiate RF ablation at the more distal points in the slow pathway, allowing for subsequent RF applications further superiorly and proximally if the initial therapy is unsuccessful. When necessary, the two methods can be combined to locate more precisely sites amenable to RFCA. When RF energy is applied to the correct site, a transient, accelerated junctional tachycardia is nearly always observed. However, this finding is not specific. Up to 65% of therapeutically ineffective RF applications are also associated with junctional tachycardias. Nonetheless, the absence of a junctional response after 10 to 15 seconds of heating should prompt discontinuation of RF delivery and movement of the ablating catheter to a different location.


For typical AVNRT, slow-pathway modification delivers a cure rate of more than 95% (see Table 33-1). There remains a small but finite risk of inadvertent AV node damage during the procedure, a complication that may require treatment with permanent cardiac pacing.


Jun 12, 2016 | Posted by in CARDIOLOGY | Comments Off on Catheter Ablation of Cardiac Arrhythmias

Full access? Get Clinical Tree

Get Clinical Tree app for offline access